drugset / Trial / NCT05815758
Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution
RandomizedParallel-groupDouble-blindTreatment
Summary
To compare the safety and tolerability of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% combination ophthalmic solution versus its vehicle in healthy adult subjects and in pediatric subjects.
Timeline
- Start
- 2023-04-20
- Primary completion
- 2023-09-18
- Completion
- 2023-09-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brimonidine | Small molecule | 0.025 % | Topical |
| Subject | Ketotifen | Small molecule | 0.035 % | Topical |